COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Events   »   Tackling Sexual Harassment for Workplace Representatives

Tackling Sexual Harassment for Workplace Representatives

The General Federation of Trade Unions (GFTU) is hosting an online course to help workplace representatives understand the nature of workplace sexual harassment, how to spot it, and how to deal with it.

Mon 20th May 2024

This one-day course will explore the reasons why sexual harassment is often not reported and the steps that unions and employers should take to ensure that harassment is taken seriously.

Date: Monday 20 May
Location: Online
Price: FREE for PDA members. £50 for non-affiliates.

REGISTER HERE

The deadline for applications for the course is 6 May 2024.

 

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists, and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)